|
U.S. Patents Awarded to Inventors in New Jersey (April 6)
(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service
Targeted News Service
ALEXANDRIA, Va., April 6 -- The following federal patents were awarded to inventors in New Jersey.
***
Lockheed Martin Assigned Patent
ALEXANDRIA, Va., April 6 -- Lockheed Martin, Bethesda, Md., has been assigned a patent (8,149,159) developed by Robert E. Yang, Cherry Hill, N.J., for a "radar coasting during data dropout."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for rapid convergence of radar target state includes the steps of using range acceleration to estimate perpendicular velocity and jump-starting a Cartesian state filter with the estimated perpendicular velocity. The improved estimate in the Cartesian state filter allows improved coasting of the range-state."
The patent application was filed on Oct. 13, 2008 (12/250,207). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,149,159&OS=8,149,159&RS=8,149,159
Written by Satyaban Rath; edited by Hemanta Panigrahi.
***
Lockheed Martin Assigned Patent
ALEXANDRIA, Va., April 6 -- Lockheed Martin, Bethesda, Md., has been assigned a patent (8,149,161) developed by Mark A. Friesel, Ewing, N.J., and Thomas R. Gillespie, Cinnaminson, N.J., for a "method and system for azimuthal containment using largest gap method."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A maximum gap method and system provide for identifying a space sector within which a system capable of engaging an object, should search for the object. A detector system that may be a radar or other active range determination system tracks position of the moving object and based on position estimates and the uncertainties associated with the position estimates, generates a range of possible positions for each estimate then determines gaps between the uncertainties and derives the search sector based on the maximum gap."
The patent application was filed on Oct. 18, 2010 (12/906,566). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,149,161&OS=8,149,161&RS=8,149,161
Written by Satyaban Rath; edited by Hemanta Panigrahi.
***
Siemens Industry Assigned Patent
ALEXANDRIA, Va., April 6 -- Siemens Industry, Alpharetta, Ga., has been assigned a patent (8,149,109) developed by Karen D. Lontka, Randolph, N.J., for a "mobile emergency device for emergency personnel."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An mobile emergency device is disclosed. The mobile emergency device includes a wireless communications component, a processor in communication with the wireless communications component, a memory in communication with the processor, the memory configured to store computer readable instructions executable by the processor. The computer readable instructions are programmed to communicate an emergency communication via the wireless communications component, wherein the emergency communication is conducted with an emergency device deployed within a building automation system, generate display data based on the received emergency communication, and communicate the display data for presentation to a user."
The patent application was filed on April 22, 2008 (12/107,423). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,149,109&OS=8,149,109&RS=8,149,109
Written by Satyaban Rath; edited by Hemanta Panigrahi.
***
Exelis Assigned Patent
ALEXANDRIA, Va., April 6 -- Exelis, McLean, Va., has been assigned a patent (8,149,162) developed by Richard J. Pauls, Lafayette, N.J., for a "methods and apparatus for N-lateration with noisy data measurements."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A technique for determining the position of a device involves generating a set of N measurements from signals transmitted by a respective set of N references devices, where the N measurements are suitable for determining a position of the device using N-lateration. Respective reliability metrics are generated for the N measurements based on information about uncertainty of individual measurements. An N-lateration computation is used to iteratively refine an estimate of the position of the device. Each iteration includes adjusting the estimate of the position of the device based on a least squares function that minimizes a sum of squares of errors between the N measurements and distances between the estimate of the position of the device and the N reference sources. The least squares function is weighted in accordance with the reliability metrics for the N measurements."
The patent application was filed on Oct. 12, 2009 (12/577,447). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,149,162&OS=8,149,162&RS=8,149,162
Written by Satyaban Rath; edited by Hemanta Panigrahi.
***
Safe-Crossings Assigned Patent
ALEXANDRIA, Va., April 6 -- Safe-Crossings, Newark, N.J., has been assigned a patent (8,149,138) developed by Thomas J. Burke, Whitehouse Station, N.J., and John Dinunzi, Easton, Pa., for a barrier gate.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A manually operated traffic barrier gate which may economically installed and maintained, and easily operated by a single individual during emergency or other critical situations. One embodiment comprises a permanently mounted barrier gate movable from a retracted, upright position to lowered position extended to bridge a preselected traffic path, wherein the gate is counterbalanced to stay in the upright position until deployed, and to be balanced to stay in the deployed state when extended. The barrier gate are operable by one person and includes locking devices to maintain their stored upright or deployed lowered position. A further embodiment of the present invention provides a dual mobile gate which may be towed singly or in a chain (dual gate one behind the other), in a retracted length to the desired location, and thereafter be disconnected from the towing vehicle and left at the site to be deployed in an extended manner or retracted and moved as needed."
The patent application was filed on Feb. 21, 2008 (12/070,691). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,149,138&OS=8,149,138&RS=8,149,138
Written by Satyaban Rath; edited by Hemanta Panigrahi.
***
Ternarylogic Assigned Patent
ALEXANDRIA, Va., April 6 -- Ternarylogic, Morristown, N.J., has been assigned a patent (8,149,143) developed by Peter Lablans, Morris Township, N.J., for a "data encryption and decryption with a key by an N-state inverter modified switching function."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and apparatus for implementing an n-state ripple-adder scheme coder with n.gtoreq.2 using an n-state reversible switching function and a non-reversible n-state switching function acting upon a first and a second word of at least 2 n-state symbols are disclosed. Corresponding decoding methods and apparatus are also disclosed. A resulting codeword may be a codeword which can be decoded by using the identical or different n-state switching functions in a corresponding ripple adder scheme decoder. Feistel networks and LFSRs apply the coding and decoding. Systems using the coding and decoding methods may be communication, storage and/or financial systems."
The patent application was filed on April 11, 2011 (13/083,763). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,149,143&OS=8,149,143&RS=8,149,143
Written by Satyaban Rath; edited by Hemanta Panigrahi.
***
Bristol-Myers Squibb Assigned Patent
ALEXANDRIA, Va., April 6 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,148,332) developed by five co-inventors for a "method for treating a rheumatic disease using a soluble TLA4 molecule." The co-inventors are Robert Cohen, Newtown, Pa., Suzette Carr, Hopewell, N.J., David Hagerty, Cardiff by the Sea, Calif., Robert James Peach, San Diego, and Jean-Claude Becker, Princeton, N.J.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to compositions and methods for treating rheumatic diseases, such as psoriasis arthropathica, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands."
The patent application was filed on July 27, 2011 (13/191,923). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,148,332.PN.&OS=PN/8,148,332&RS=PN/8,148,332
Written by Shabnam Sheikh; edited by Jaya Anand.
***
New York Blood Center Assigned Patent
ALEXANDRIA, Va., April 6 -- New York Blood Center, New York, has been assigned a patent (8,148,320) developed by Leszek Kotula, Marlboro, N.J., and Xiaoling Xiong, Fresh Meadows, N.Y., for "peptide inhibitors of ABL kinases."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are purified compounds comprising SEQ ID NO:1, where the tyrosine at residue (10) is phosphorylated. Also provided are purified compounds comprising SEQ ID NO:1, where the amino acid sequence of the compound is less than 400 amino acids. Additionally provided are methods of determining whether an agent is a candidate inhibitor of an AbI kinase. Further provided are methods of inhibiting an AbI kinase. Also provided are methods of treating a patient having a condition characterized by a mutant AbI kinase. Additionally provided are methods of treating a patient at risk for a condition characterized by a mutant AbI kinase. Methods of labeling an AbI kinase are also provided. Additionally, methods of isolating an AbI kinase from a tissue are provided."
The patent application was filed on Nov. 29, 2006 (12/095,728). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,148,320.PN.&OS=PN/8,148,320&RS=PN/8,148,320
Written by Shabnam Sheikh; edited by Jaya Anand.
***
Honeywell International Assigned Patent
ALEXANDRIA, Va., April 6 -- Honeywell International, Morristown, N.J., has been assigned a patent (8,148,317) developed by five co-inventors for "azeotrope-like compositions of tetrafluoropropene and hydrofluorocarbons." The co-inventors are Rajiv R. Singh, Getzville, N.Y., Hang T. Pham, Amherst, N.Y., Gary Knopeck, Lakeview, N.Y., Louis E. Herena, Scarsdale, N.Y., and Jeremy N. Diringer, Morristown, N.J.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are azeotrope-like compositions comprising tetrafluoropropene and hydrofluorocarbons and uses thereof, including use in refrigerant compositions, refrigeration systems, blowing agent compositions, and aerosol propellants."
The patent application was filed on July 28, 2009 (12/511,018). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,148,317.PN.&OS=PN/8,148,317&RS=PN/8,148,317
Written by Shabnam Sheikh; edited by Jaya Anand.
***
ExxonMobil Research and Engineering Assigned Patent
ALEXANDRIA, Va., April 6 -- ExxonMobil Research and Engineering, Annandale, N.J., has been assigned a patent (8,148,292) developed by five co-inventors for a "preparation of high activity cobalt catalysts, the catalysts and their use." The co-inventors are Stuart L. Soled, Pittstown, N.J., Joseph E. Baumgartner, Califon, N.J., Christine E. Kliewer, Clinton, N.J., El-Mekki El-Malki, Falls Church, Va., and Patricia A. Bielenberg, Easton, Pa.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is provided for preparing a supported cobalt-containing catalyst having substantially homogenously dispersed, small cobalt crystallites. The method comprises depositing cobalt nitrate on a support and then heating the support in an oxygen-containing, substantially water-free atmosphere to about 160.degree. C. to form an intermediate decomposition product. This intermediate decomposition product is then calcined and reduced."
The patent application was filed on July 23, 2009 (12/460,722). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,148,292.PN.&OS=PN/8,148,292&RS=PN/8,148,292
Written by Shabnam Sheikh; edited by Jaya Anand.
***
Basf Assigned Patent
ALEXANDRIA, Va., April 6 -- Basf, Florham Park, N.J., has been assigned a patent (8,148,290) developed by four co-inventors for a "diesel exhaust treatment system catalyst monitoring." The co-inventors are Torsten Wolfgang Mueller, Hannover, Germany, Tilman Wolfram Beutel, Neshanic Station, N.J., Joseph Charles Dettling, Howell, N.J., and Markus Kinne, Hannover, Germany.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Diesel exhaust treatment articles, systems and methods are disclosed. According to one or more embodiments, an oxygen storage component is utilized and degradation of the oxygen storage component is correlated with degradation of the hydrocarbon conversion efficiency of a catalyst in a diesel engine system."
The patent application was filed on June 27, 2006 (11/426,792). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,148,290.PN.&OS=PN/8,148,290&RS=PN/8,148,290
Written by Shabnam Sheikh; edited by Jaya Anand.
***
General Electric Assigned Patent
ALEXANDRIA, Va., April 6 -- General Electric, Schenectady, N.Y., has been assigned a patent (8,148,166) developed by four co-inventors for a "method and apparatus for measuring pH of low alkalinity solutions." The co-inventors are Bingzhi Chen, Shanghai, China, Weiyi Cui, Piscataway, N.J., Li Zhang, Shanghai, China, and Caibin Xiao, Harleysville, Pa.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods are described for measuring pH of low alkalinity samples. The present invention provides a sensor array comprising a plurality of pH indicators, each indicator having a different indicator concentration. A calibration function is generated by applying the sensor array to a sample solution having a known pH such that pH responses from each indicator are simultaneously recorded versus indicator concentration for each indicator. Once calibrated, the sensor array is applied to low alkalinity samples having unknown pH. Results from each pH indicator are then compared to the calibration function, and fitting functions are extrapolated to obtain the actual pH of the low alkalinity sample."
The patent application was filed on May 18, 2011 (13/110,047). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,148,166.PN.&OS=PN/8,148,166&RS=PN/8,148,166
Written by Shabnam Sheikh; edited by Jaya Anand.
***
Ortho-Clinical Diagnostics Assigned Patent
ALEXANDRIA, Va., April 6 -- Ortho-Clinical Diagnostics, Raritan, N.J., has been assigned a patent (8,148,157) developed by John W. Backus, Ontario, N.Y., Jian Zheng, Raritan, N.J., and George Bashirians, Penfield, N.Y., for a "reference, calibrator, or control composition of PIGF-1 and sFlt-1."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed herein are compositions and methods comprising two or more proteins in which at least one of the proteins has been altered to reduce their mutual recognition and binding. Such compositions are useful as reference, calibrators or controls in methods and assays for determining the amount of one or more of the proteins that may be present in a sample of interest or in confirming the presence of one or more of the proteins in the sample. More particularly, it relates to compositions and methods comprising altered placental growth factor-1 (PlGF-1) and soluble fms-like tyrosine kinase (sFlt-1) and methods for determining the amount or confirming the presence of sFlt-1 and/or PlGF-1 in a sample of interest."
The patent application was filed on Jan. 7, 2009 (12/349,695). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,148,157.PN.&OS=PN/8,148,157&RS=PN/8,148,157
Written by Shabnam Sheikh; edited by Jaya Anand.
***
Universal Display Assigned Patent
ALEXANDRIA, Va., April 6 -- Universal Display, Ewing, N.J., has been assigned a patent (8,148,891) developed by four co-inventors for an "electron impeding layer for high efficiency phosphorescent OLEDs." The co-inventors are Yeh Tung, Princeton, N.J., Brian W. D'Andrade, Westampton, N.J., Michael S. Weaver, Princeton, N.J., and James Esler, Levittown, Pa.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to OLEDs comprising an electron impeding layer between the cathode and the emissive layer. An organic light emitting device, comprising: an anode; a hole transport layer; an organic emissive layer comprising an emissive layer host and an emissive dopant; an electron impeding layer; an electron transport layer; and a cathode disposed, in that order, over a substrate."
The patent application was filed on Oct. 4, 2005 (11/242,025). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,891&OS=8,148,891&RS=8,148,891
Written by Kusum Sangma; edited by Anand Kumar.
***
Emisphere Technologies Assigned Patent
ALEXANDRIA, Va., April 6 -- Emisphere Technologies, Cedar Knolls, N.J., has been assigned a patent (8,148,578) developed by David Gschneidner, Cedar Knolls, N.J., for a "fast acting naratriptan composition."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to pharmaceutical compositions containing Naratriptan, a compound selected from the group consisting of 2-HPOD, 2-HPHM, 4-PPED, 4-BPED and 2-PPED, and optionally, a pharmaceutically acceptable excipient."
The patent application was filed on Aug. 12, 2011 (13/208,644). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,578&OS=8,148,578&RS=8,148,578
Written by Arpi Sharma; edited by Anand Kumar.
***
McNeil-PPC Assigned Patent
ALEXANDRIA, Va., April 6 -- McNeil-PPC, Skillman, N.J., has been assigned a patent (8,148,597) developed by David Gubernick, Cherry Hill, N.J., and Peter W. Jackson, Hampton, N.J., for an "absorbent article having stain resistant properties."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A sanitary napkin including a body facing surface, a portion adapted to be arranged over the vaginal opening during use, a first colored portion, said colored portion extending over at least the portion of the napkin to be placed over the vaginal opening during use, a noncolored portion, wherein said first colored portion has a first color as measured from said body facing surface prior to staining, wherein the first colored portion has a second color as measured from said body facing surface after staining, wherein the first color has an average L value greater than 80; and wherein a .DELTA.a* between said first color and said second color is less than 18."
The patent application was filed on Oct. 17, 2006 (11/550,149). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,597&OS=8,148,597&RS=8,148,597
Written by Arpi Sharma; edited by Anand Kumar.
***
Teva Women's Health Assigned Patent
ALEXANDRIA, Va., April 6 -- Teva Women's Health, Woodcliff Lake, N.J., has been assigned a patent (8,148,560) developed by Salah U. Ahmed, New City, N.Y., and Raj R. Mahajan, Lodi, N.J., for a "vaginal tablets comprising misoprostol and methods of making and using the same."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to vaginal tablets comprising misoprostol and a pharmaceutically acceptable pH insensitive, hydrophilic cellulose material, wherein the vaginal tablets do not contain a hydrophobic release controlling agent, and wherein the misoprostol and the pharmaceutically acceptable pH insensitive, hydrophilic cellulose material are in a ratio of about 1:50 to about 1:800, and wherein the vaginal tablets do not substantially change the pH of a vaginal tract."
The patent application was filed on Sept. 25, 2006 (11/526,240). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,560&OS=8,148,560&RS=8,148,560
Written by Arpi Sharma; edited by Anand Kumar.
***
ExxonMobil Chemical Patents Assigned Patent for Process to Produce a Hydrocarbon Rubber Cement Utilizing a Hydrofluorocarbon Diluent
ALEXANDRIA, Va., April 6 -- ExxonMobil Chemical Patents, Houston, has been assigned a patent (8,148,450) developed by five co-inventors for a "process to produce a hydrocarbon rubber cement utilizing a hydrofluorocarbon diluent." The co-inventors are Michael F. McDonald, Kingwood, Texas, Scott T. Milner, Somerville, N.J., Timothy D. Shaffer, Hackettstown, N.J., Robert N. Webb, Kingwood, Texas, and Richard D. Hembree, Zachary, La.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided for herein is a process to produce an essentially homogeneous single liquid phase hydrocarbon-rubber cement from a polymer slurry comprising a hydrocarbon-rubber, a diluent, and unreacted monomer(s), the process comprising: (a) contacting the polymer slurry with a hydrocarbon solvent; and (b) removing the diluent in amounts not sufficiently more than is necessary to produce the essentially homogeneous single liquid phase hydrocarbon-rubber cement wherein the mass fraction of monomer(s) in the hydrocarbon-rubber cement, based on the total amount of hydrocarbon-rubber present in the hydrocarbon-rubber cement, is less than the mass fraction of monomer(s) in the hydrocarbon-rubber slurry, based on the total amount of hydrocarbon-rubber present in the hydrocarbon-rubber slurry, wherein the diluent comprises a hydrofluorocarbon."
The patent application was filed on June 23, 2006 (11/473,732). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,450&OS=8,148,450&RS=8,148,450
Written by Arpi Sharma; edited by Anand Kumar.
***
Accelergy Assigned Patent
ALEXANDRIA, Va., April 6 -- Accelergy, Houston, has been assigned a patent (8,148,435) developed by Rocco A. Fiato, Basking Ridge, N.J., for an "integrated coal to liquids process and system."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An integrated coal-to-liquids process is provided to minimize carbon dioxide emissions and efficiently make use of carbon resources, by recovering carbon dioxide emissions from Coal-to-Liquids (CTL) facilities, using the recovered carbon dioxide in at least one carbonylation reaction step for converting ammonia to urea and then converting urea into dimethyl carbonate."
The patent application was filed on May 21, 2009 (12/470,072). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,435&OS=8,148,435&RS=8,148,435
Written by Arpi Sharma; edited by Anand Kumar.
***
Bristol-Myers Squibb Assigned Patent for Kinase Inhibitors
ALEXANDRIA, Va., April 6 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,148,361) developed by Rajeev S. Bhide, Princeton Junction, N.J., and Anne Marinier, Kirkland, Canada, for kinase inhibitors.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts thereof. The Formula (I) compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1 and IGFR-1, thereby making them useful as anti-cancer agents. The formula (I) compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors. ##STR00001##."
The patent application was filed on Nov. 7, 2007 (12/513,928). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,361&OS=8,148,361&RS=8,148,361
Written by Arpi Sharma; edited by Anand Kumar.
***
ExxonMobil Research and Engineering Assigned Patent
ALEXANDRIA, Va., April 6 -- ExxonMobil Research and Engineering, Annandale, N.J., has been assigned a patent (8,148,472) developed by Lisa Saunders Baugh, Ringoes, N.J., Bryan R. Chapman, Annandale, N.J., and Enock Berluche, Phillipsburg, N.J., for a "polymer compositions comprising cyclic olefin polymers, polyolefin modifiers and non-functionalized plasticizers."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to a polymer composition comprising a blend comprising: (a) greater than 30 wt (based upon the weight of the composition) of a cyclic olefin polymer having a T.sub.g greater than 60.degree. C. and having a T.sub.m heat of fusion (.DELTA.H.sub.f) of 40 J/g or less selected from the group consisting of: i) copolymers comprising at least one acyclic olefin and at least 15 mole % of one or more cyclic olefins; ii) partially or completely hydrogenated copolymers comprising at least one acyclic olefin and at least 15 mole % of one or more cyclic olefins; iii) metathesis copolymers comprising two or more cyclic olefins; iv) partially or completely hydrogenated metathesis copolymers comprising two or more cyclic olefins; v) metathesis homopolymers comprising cyclic olefins; vi) partially or completely hydrogenated metathesis homopolymers comprising cyclic olefins; and vii) mixtures thereof; (b) from 1 to 50 wt % (based upon the weight of the composition) of an acyclic olefin polymer modifier having a glass transition temperature of less than 0.degree. C.; (c) from 0.1 to 50 wt % (based upon the weight of the composition) of a non-functionalized plasticizer having a kinematic viscosity at 100.degree. C. of 3 to 3000 cSt, a viscosity index of 120 or more, a pour point of 0.degree. C. or less and a flash point of 200.degree. C. or more."
The patent application was filed on Feb. 1, 2008 (12/012,380). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,472&OS=8,148,472&RS=8,148,472
Written by Arpi Sharma; edited by Anand Kumar.
***
Phoenix Chemical, Siltech Assigned Patent
ALEXANDRIA, Va., April 6 -- Phoenix Chemical, Somerville, N.J., and Siltech, Toronto, have been assigned a patent (8,148,483) developed by Anthony John O'Lenick Jr., Dacula, Ga., and John Imperante, Califon, N.J., for a "fluoro silicone acrylates and polymers thereof."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to fluoro silicone acrylates that are used in reaction either alone or with other monomers to make polymers that can modify the surface of hair skin or pigment. This makes them ideal for incorporation into pigmented products in personal care applications like make up and lipsticks."
The patent application was filed on Aug. 30, 2010 (12/807,139). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,483&OS=8,148,483&RS=8,148,483
Written by Arpi Sharma; edited by Anand Kumar.
***
Bristol-Myers Squibb Assigned Patent
ALEXANDRIA, Va., April 6 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,148,400) developed by seven co-inventors for a "thiazolyl compounds useful as kinase inhibitors." The co-inventors are Anne Marinier, Kirkland, Canada, Claude A. Quesnelle, Skillman, N.J., Marco Dodier, Wotton, Canada, Stephan Roy, Levis, Canada, Patrice Gill, Levittown, Pa., Mark D. Wittman, Wallingford, Conn., and David R. Langley, Meriden, Conn.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides compounds of formula II: ##STR00001## and pharmaceutically acceptable salts thereof. The formula II thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease."
The patent application was filed on Dec. 19, 2007 (12/519,597). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,400&OS=8,148,400&RS=8,148,400
Written by Arpi Sharma; edited by Anand Kumar.
***
NPS Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., April 6 -- NPS Pharmaceuticals, Bedminster, N.J., has been assigned a patent (8,148,394) developed by four co-inventors for "azaindoles having serotonin receptor affinity." The co-inventors are Louise Edwards, Mississauga, Canada, Abdelmalik Slassi, Mississauga, Canada, Ashok Tehim, Ridgewood, N.J., and Tao Xin, Toronto.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are compounds with affinity for the 5-HT.sub.6 receptor, which have the general formula I: ##STR00001## wherein A, B, D, E, R.sub.1 to R.sub.3 and n are described herein. Also described is the use of these compounds as pharmaceuticals to treat indications where inhibition of the 5-HT.sub.6 receptor is implicated, such as schizophrenia."
The patent application was filed on Aug. 7, 2007 (11/835,325). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,394&OS=8,148,394&RS=8,148,394
Written by Arpi Sharma; edited by Anand Kumar.
***
Istituto di Ricerche di Biologia Molecolare P. Angeletti, Merck Sharp & Dohme Assigned Patent
ALEXANDRIA, Va., April 6 -- Istituto di Ricerche di Biologia Molecolare P. Angeletti, Rome, and Merck Sharp & Dohme, Rahway, N.J., have been assigned a patent (8,148,349) developed by five co-inventors for a "nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection." The co-inventors are Malte Meppen, Rome, Frank Narjes, Rome, Barbara Pacini, Rome, Cristina Gardelli, Rome, and Philippe L. Durette, New Providence, N.J.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides nucleoside cyclic phosphoramidates of formula (I), pharmaceutical compositions comprising the compounds of formula (I) and methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection using the compounds of formula (I). ##STR00001##."
The patent application was filed on Dec. 14, 2007 (12/519,038). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,349&OS=8,148,349&RS=8,148,349
Written by Arpi Sharma; edited by Anand Kumar.
***
Bristol-Myers Squibb Assigned Patent for Triazolopyridine 11-beta Hydroxysteroid Dehydrogenase Type I Inhibitors
ALEXANDRIA, Va., April 6 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,148,396) developed by seven co-inventors for a "triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors." The co-inventors are James J. Li, Pennington, N.J., Lawrence G. Hamann, North Grafton, Mass., Haixia Wang, Colombus, N.J., Zheming Ruan, Dayton, N.J., Christopher B. Cooper, Lawrenceville, N.J., Jun Li, Princeton, N.J., and Jeffrey A. Robl, Newtown, Pa.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: ##STR00001## or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof wherein W, L, R.sub.3, R.sub.3a, R.sub.3b and R.sub.4 are defined herein."
The patent application was filed on April 16, 2009 (12/424,674). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,396&OS=8,148,396&RS=8,148,396
Written by Arpi Sharma; edited by Anand Kumar.
***
Schering Assigned Patent for Heterocyclic Compounds as Factor IXA Inhibitors
ALEXANDRIA, Va., April 6 -- Schering, Kenilworth, N.J., has been assigned a patent (8,148,363) developed by twelve co-inventors for a "heterocyclic compounds as factor IXA inhibitors." The co-inventors are Martin C. Clasby, Plainsboro, N.J., William J. Greenlee, Teaneck, N.J., Yan Xia, Edison, N.J., Tin-Yau Chan, Edison, N.J., Mariappan V. Chelliah, Edison, N.J., Samuel Chackalamannil, Califon, N.J., Haiyan Pu, Livingston, N.J., Keith A. Eagen, Long Valley, N.J., Henry Vaccaro, South Plainfield, N.J., Brian A. McKittrick, New Vernon, N.J., Liyuan Wang, Warren, N.J., and Xiaobang Gao, Conshohocken, Pa.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to novel heterocyclic compounds of Formulae I-III; as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder. ##STR00001##."
The patent application was filed on May 18, 2009 (12/993,607). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,363&OS=8,148,363&RS=8,148,363
Written by Arpi Sharma; edited by Anand Kumar.
***
Univation Technologies Assigned Patent
ALEXANDRIA, Va., April 6 -- Univation Technologies, Houston, has been assigned a patent (8,148,481) developed by five co-inventors for a "method for seed bed treatment for a polymerization reaction." The co-inventors are F. David Hussein, Cross Lanes, W.Va., Mark G. Goode, Hurricane, W.Va., Michael E. Muhle, Kingwood, Texas, David A. Yahn, Singapore, and Robert O. Hagerty, Wyckoff, N.J.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for preparing a reactor for performance of a polymerization reaction, the method including providing at least one seed bed into the reactor; wherein the at least one seed bed includes at least one organometallic compound and polymer particles."
The patent application was filed on Dec. 17, 2009 (13/128,087). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,481&OS=8,148,481&RS=8,148,481
Written by Arpi Sharma; edited by Anand Kumar.
***
QUALCOMM Assigned Patent for Method of Downlink Resource Allocation in a Sectorized Environment
ALEXANDRIA, Va., April 6 -- QUALCOMM, San Diego, has been assigned a patent (8,149,766) developed by Rajiv Laroia, Basking Ridge, N.J., and Junyi Li, Bedminister, N.J., for a "method of downlink resource allocation in a sectorized environment."
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and apparatus for communicating different size coded blocks of information in a wireless sectorized communications cell are described. Information may be categorized and formed into large, medium, and small coded blocks which may include error correction code bits based on the number of bits representing the information, time criticality of the information, and tolerable level of interference. Channels with full tone overlap between adjacent sectors, channels with no tone overlap between adjacent sectors, and channels with partial tone overlap between adjacent sectors are used for different size blocks. Some tones corresponding to a channel with less than full tone overlap are left unused in an adjacent sector thereby achieving less than full transmission tone overlap. Large transmission blocks are transmitted using full tone overlap channels; medium transmission blocks are transmitted using partial tone overlap channels; small transmission blocks are transmitted without using transmission tone overlap in adjacent sectors."
The patent application was filed on June 11, 2007 (11/761,355). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,149,766&OS=8,149,766&RS=8,149,766
Written by Arpi Sharma; edited by Anand Kumar.
***
Cephalon Assigned Patent
ALEXANDRIA, Va., April 6 -- Cephalon, Frazer, Pa., has been assigned a patent (8,148,391) developed by 22 co-inventors for a "fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors." The co-inventors are Gulzar Ahmed, Voorhees, N.J., Henry Joseph Breslin, Lansdale, Pa., Jason Burke, Charlottesville, Va., Matthew A. Curry, Coatesville, Pa., James L. Diebold, Eagleville, Pa., Bruce Dorsey, Ambler, Pa., Benjamin J. Dugan, Glen Mills, Pa., Daming Feng, East Windsor, N.J., Diane E. Gingrich, Downingtown, Pa., Tao Guo, Dayton, N.J., Keith S. Learn, Perkiomenville, Pa., Joseph G. Lisko, Glenmoore, Pa., Rong-Qiang Liu, Kendall Park, N.J., Eugen Florin Mesaros, Philadelphia, Karen Milkiewicz, Exton, Pa., Gregory R. Ott, Media, Pa., Jay P. Theroff, West Chester, Pa., Tho V. Thieu, Ambler, Pa., Rabindranath Tripathy, Churchville, Pa., Theodore L. Underiner, Malvern, Pa., Gregory J. Wells, West Chester, Pa., and Craig A. Zificsak, Downingtown, Pa.
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, A.sup.1, A.sup.2, A.sup.3, A.sup.4, and A.sup.5, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders. ##STR00001##."
The patent application was filed on Oct. 23, 2007 (12/162,851). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,148,391&OS=8,148,391&RS=8,148,391
Written by Arpi Sharma; edited by Anand Kumar.
For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.
-1081501
(c) 2012 Targeted News Service
[ Back To LatinAmerica.tmcnet.com's Homepage 's Homepage ]
|
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
